Merck’s COVID pill shows lower efficacy in updated studyDrugmaker says final analysis of trial results showed molnupiravir showed 30 percent risk reduction.
Merck’s COVID pill shows lower efficacy in updated study
Subscribe to:
Post Comments (Atom)
Post a Comment Blogger Facebook